Back
Speaker illustration

Doctor Peter Kistler

The Alfred Hospital, Melbourne (Australia)

Professor Peter Kistler is a clinician cardiologist and electrophysiologist. He is the Head of electrophysiology at the Alfred Hospital and Head of Clinical Electrophysiology research at the Baker Heart Institute in Melbourne, Australia. He is a Professor in the department of Medicine at the University of Melbourne and Monash Universities. Peter has made a substantial contribution to the field of atrial arrhythmias with 223 publications, 6467 citations and has supervised 18 PhD students. He was the senior author of the first randomized study defining the role of alcohol abstinence in atrial fibrillation published in NEJM in 2020 and the CAMERA-MRI study 2017. Peter was awarded the prestigious RT Hall Prize from CSANZ in 2020 for excellence in cardiac research. He is an invited speaker at the American Heart Association, Heart Rhythm Society (USA) and Asia-Pacific Heart Rhythm Society. He is the current Chair of the Cardiac Society Australia New Zealand AF ablation guidelines.

Presentations Articles

Catheter ablation in persistent atrial fibrillation: long term outcomes of the CAPLA multicentre randomised trial of pulmonary vein isolation(PVI) vs PVI plus posterior left atrial wall isolation(PWI)

Event: ESC Congress 2024

Topic: Rhythm Control, Catheter Ablation

Session: Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment

Access
Like
Thumbnail

Posterior wall isolation improves outcomes for persistent atrial fibrillation with rapid posterior wall activity: a CAPLA substudy

Event: ESC Congress 2023

Topic: Catheter Ablation of Arrhythmias

Session: Clinical trial updates on atrial fibrillation

Access
Like
Thumbnail

Minimising alcohol intake to reduce atrial fibrillation burden

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session: Lifestyle modifications in atrial fibrillation: what to advise your patient

Access
Like
Thumbnail

Catheter ablation in atrial fibrillation and heart failure with preserved ejection fraction improves peak pulmonary capillary wedge pressure, exercise capacity and quality of life: RCT STALL HFpEF

Event: ESC Congress 2022

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation ablation and outcome

Access
Like
Thumbnail

Development and validation of the harms2-af lifestyle risk score to predict incident AF

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment - Scores 2

Access
Like
Thumbnail

Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Event: ESC Congress 2022

Topic: Rhythm Control, Cardioversion

Session: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Access
Like
Thumbnail

CAPLA – randomized trial of pulmonary vein isolation (PVI) with posterior wall isolation (PWI) in persistent atrial fibrillation.

Event: ESC Congress 2022

Topic: Rhythm Control, Catheter Ablation

Session: Latest science in atrial fibrillation ablation

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources